Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,388,121
+$348,245 QoQ
Shares Held
33,028
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,211
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. JNJ ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,388,121 | 33,028 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,039,876 | 32,891 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,783,596 | 37,611 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,035,576 | 37,944 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $5,763,410 | 37,731 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,962,113 | 35,951 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $5,084,405 | 35,157 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,959,918 | 36,776 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,268,921 | 36,049 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,703,065 | 36,052 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,150,164 | 39,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,233,426 | 40,022 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,308,132 | 38,111 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,962,230 | 38,466 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $6,749,089 | 38,206 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,144,459 | 37,613 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,720,706 | 37,861 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,541,490 | 42,552 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,055,953 | 41,246 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,661,059 | 35,053 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,910,706 | 35,879 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,864,501 | 35,683 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $5,722,808 | 36,363 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,192,190 | 34,875 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $4,676,510 | 33,254 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,343,681 | 33,125 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||